The CDC’s vaccine panel will meet Friday to determine whether the extra shots should be recommended for all adults.
Category: breaking-news
Biden’s Covid-19 Vaccine Mandate Is On Hold, But Here Are Companies Requiring Shots Anyway
As President Biden’s vaccine mandate for large employers is challenged in court, many businesses are still going ahead with the requirement.
U.S. Inks $5.3 Billion Deal For Pfizer’s Antiviral Covid Pill — Growing Its Stockpile Of New Coronavirus Treatments
The deal will secure the U.S. 10 million courses of Pfizer’s experimental Covid-19 pill, providing it is approved by regulators.
Nearly One Third Of Healthcare Workers In U.S. Hospitals Are Still Not Vaccinated Against Covid-19, CDC Study Finds, As Vaccine Mandate Looms
Around 70% of healthcare workers in U.S. hospitals were fully vaccinated against Covid-19 as of September 15, according to the CDC study, with higher rates found among workers in children’s hospitals and urban areas.
Mask Wearing Cuts New Covid-19 Cases By 53%—It’s The Best Public Health Measure Against The Virus, Study Finds
The measure has been a flashpoint during the pandemic, but researchers say it’s more effective than handwashing and physical distancing at reducing the incidence of Covid-19.
About 10% Of Kids Ages 5 To 11 Partially Vaccinated, White House Says
Though many parents remain hesitant about vaccinating their children ages 5 to 11 against Covid-19, the White House shared encouraging signs for the vaccine rollout to this point.
European Regulator Starts Assessing Novavax’s Covid Vaccine—Stock Jumps 8%
The European Medicines Agency said it could make a decision on the shot “within weeks.”
U.S. Reportedly Buying 10 Million Courses Of Pfizer Antiviral Pills
Pfizer has said its drug to treat Covid-19 reduced the risk of hospitalization or death due to the disease by 89% compared to a placebo.
Pfizer Is Submitting Its Covid Antiviral To The FDA For Emergency Authorization
If authorized, the pill would be the first of its kind to treat Covid.
Pfizer Signs Deal To Share Its Covid Antiviral Pill With Low Income Nations
The pharmaceutical giant and its development partner Ridgeback Therapeutics signed a licensing deal that will boost access to their new drug.
